Effect of dsDNA on the Assembly Pathway and Mechanical Strength of SV40 VP1 Virus-like Particles.

Biophys J

Moleculaire Biofysica, Zernike Instituut, Rijksuniversiteit Groningen, Groningen, The Netherlands. Electronic address:

Published: November 2018

Simian virus 40 (SV40) is a possible vehicle for targeted drug delivery systems because of its low immunogenicity, high infectivity, and high transfection efficiency. To use SV40 for biotechnology applications, more information is needed on its assembly process to efficiently incorporate foreign materials and to tune the mechanical properties of the structure. We use atomic force microscopy to determine the effect of double-stranded DNA packaging, buffer conditions, and incubation time on the morphology and strength of virus-like particles (VLPs) composed of SV40 VP1 pentamers. DNA-induced assembly results in a homogeneous population of native-like, ∼45 nm VLPs. In contrast, under high-ionic-strength conditions, the VP1 pentamers do not seem to interact consistently, resulting in a heterogeneous population of empty VLPs. The stiffness of both in-vitro-assembled empty and DNA-filled VLPs is comparable. Yet, the DNA increases the VLPs' resistance to large deformation forces by acting as a scaffold, holding the VP1 pentamers together. Both disulfide bridges and Ca, important in-vitro-assembly factors, affect the mechanical stability of the VLPs: the reducing agent DTT makes the VLPs less resistant to mechanical stress and prone to damage, whereas Ca-chelating EDTA induces a marked softening of the VLP. These results show that negatively charged polymers such as DNA can be used to generate homogeneous particles, thereby optimizing VLPs as vessels for drug delivery. Moreover, the storage buffer should be chosen such that VP1 interpentamer interactions are preserved.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225054PMC
http://dx.doi.org/10.1016/j.bpj.2018.07.044DOI Listing

Publication Analysis

Top Keywords

vp1 pentamers
12
sv40 vp1
8
virus-like particles
8
drug delivery
8
vlps
7
vp1
5
dsdna assembly
4
assembly pathway
4
pathway and mechanical
4
and mechanical strength
4

Similar Publications

Discovery, recognized antigenic structures, and evolution of cross-serotype broadly neutralizing antibodies from porcine B-cell repertoires against foot-and-mouth disease virus.

PLoS Pathog

October 2024

State Key Laboratory for Animal Disease Control and Prevention, College of Veterinary Medicine, Lanzhou University, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, P. R. China.

Article Synopsis
  • The study investigates the challenge of isolating broadly neutralizing antibodies (bnAbs) against foot-and-mouth disease virus (FMDV), which has seven distinct serotypes and lacks cross-protection.
  • By vaccinating pigs with serotypes O and A, researchers identified 10 bnAbs through analysis of a large number of B cell clones, showing that sequential vaccination can induce cross-serotype bnAbs.
  • The bnAbs mainly target a conserved motif on a viral protein to inhibit cell attachment, while one specific bnAb (pOA-2) binds to a new viral structure, revealing the importance of B-cell mutations in achieving effective neutralization.
View Article and Find Full Text PDF

Reactivation of BK polyomavirus (BKPyV) can cause significant kidney and bladder disease in immunocompromised patients. There are currently no effective, BKPyV-specific therapies. MAU868 is a novel, human immunoglobulin (Ig) G1 monoclonal antibody that binds the major capsid protein, VP1, of BKPyV with picomolar affinity, neutralizes infection by the 4 major BKPyV genotypes (EC ranging from 0.

View Article and Find Full Text PDF

Effect of ionic strength on the assembly of simian vacuolating virus capsid protein around poly(styrene sulfonate).

Eur Phys J E Soft Matter

November 2023

Institute of Chemistry and the Center for Nanoscience and Nanotechnology, The Hebrew University of Jerusalem, Edmond J. Safra Campus, Givat Ram, 9190401, Jerusalem, Israel.

Virus-like particles (VLPs) are noninfectious nanocapsules that can be used for drug delivery or vaccine applications. VLPs can be assembled from virus capsid proteins around a condensing agent, such as RNA, DNA, or a charged polymer. Electrostatic interactions play an important role in the assembly reaction.

View Article and Find Full Text PDF
Article Synopsis
  • Polyomaviruses (PyVs) have been discovered in vesper bats across Central Europe, with seven partial VP1 sequences identified from six different bat species.
  • Using advanced methods, complete genomes of two new bat PyV species were determined, classified as Alphapolyomavirus epserotinus and Alphapolyomavirus myodaubentonii, based on significant genetic differences.
  • Phylogenetic analysis positioned these new species alongside other bat PyVs from various continents, while protein modeling revealed differences in their capsid proteins compared to murine polyomavirus, highlighting their unique characteristics.
View Article and Find Full Text PDF

Vaccination with intact (146S) foot-and-mouth disease virus (FMDV) particles is used to control FMD. However, 146S particles easily dissociate into stable pentameric 12S particles which are less immunogenic. We earlier isolated several single-domain antibody fragments (VHHs) that specifically bind either 146S or 12S particles.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!